TORONTO — Canada’s only licensed cannabis producer focused on the female health and wellness market, 48North Cannabis Corp. is announcing the launch of Latitude. Latitude is an online platform that empowers, educates and breaks taboos through storytelling and authentic experiences of women and their cannabis use.
Beautifully curated with profiles, photo essays, infographics and a glossary of cannabis terms, Latitude speaks to a diverse group of women seeking to explore new latitudes with cannabis. Research indicates that 41 percent of current Canadian cannabis users are women and that 27% of adults who have used cannabis in the past will do so more often once legalized. However, there are many Canadians still unsure of cannabis and Latitude provides a safe, stigma-busting space to host these discussions.
“Knowing that women make up nearly half of the current Canadian cannabis market, our goal with Latitude is to host candid, judgment-free conversations about cannabis,” Alison Gordon, CEO of 48North, Canada’s first female CEO of a publicly-traded licensed producer of cannabis, said. “Through sharing our stories, we can connect with women looking to evolve their path to well-being. Latitude is a resource to support women as they navigate the world of cannabis.”
Through Latitude, 48North aims to foster a growing community of cannabis advocates and ambassadors to lead conversations about breaking down the stigma of cannabis use. By representing real women sharing candid stories, Latitude offers women permission and agency to do what they need to do in order to make informed decisions about cannabis.
Want to share your cannabis story? Please visit www.explorelatitude.com
* Research conducted by Morawski & Associates and maru/matchbox for 48North Cannabis Corp.
About 48North Cannabis Corp.
48North Cannabis Corp. is a TSX Venture Exchange listed company whose wholly owned subsidiary DelShen Therapeutics Corp. (“DelShen”), is a licensed producer of cannabis in Canada. 48North grows unique genetics sourced from MariPharm B.V., a Netherlands-based phytopharmaceutical company with over 25 years of experience in the research and cultivation of cannabis for medical purposes. Its genetics are grown to exacting standards, ensuring patients can count on receiving the highest-quality cannabis products.
DelShen is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and the facility is located on 800-acres of owned land near Kirkland Lake, Ontario. DelShen’s license to produce cannabis was granted on February 28, 2017, and pertains to the facility, a state-of-the-art, closed-box, 40,000-square-foot building with an additional 200,000 square feet of production space planned within the current security perimeter.